13Nov
Covid–19 coronavirus: global merger review (updated 13 November 2020)
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). The table below reflects our understanding of the current effects on the merger review process in numerous jurisdictions around the world. It...
By:
Allen & Overy LLP
Related
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with t...
Read More >
The covid-19 pandemic has dramatically altered all aspects of life. The acquisition and leverage fin...
Read More >
December 19, 2019, Congress finally passed the Setting Every Community Up for Retirement Enhancement...
Read More >
The U.S. women’s soccer team celebrated their victory over the Netherlands at a victory parade in L...
Read More >
New York Governor Andrew Cuomo recently signed legislation amending state law to explicitly prohibit...
Read More >
On November 15, 2019, the United States Department of Labor (DOL) and the United States Department o...
Read More >